More than 100 cancer specialists have banded together to persuade pharmaceutical companies to bring prices down, suggesting that the high prices for medicine needed to keep someone alive is profiteering.
By ANDREW POLLACK, New York Times
Thu, 04/25/2013 - 7:03am
More than 100 cancer specialists have banded together to persuade pharmaceutical companies to bring prices down, suggesting that the high prices for medicine needed to keep someone alive is profiteering.